Cognitive functioning related to quality of life in schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 1, 2008, Pages 280-287

  Matsui, Mié ^a,b   Sumiyoshi, Tomiki ^a,b   Arai, Hirofumi ^a,b   Higuchi, Yuko ^a   Kurachi, Masayoshi ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Executive function; Quality of life; Schizophrenia; Social knowledge; Verbal memory

Indexed keywords

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; EMPATHY; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEUROPSYCHOLOGICAL TEST; QUALITY OF LIFE; RATING SCALE; RULE SHIFT CARD TEST; SCHIZOPHRENIA; SCHIZOPHRENIA QUALITY OF LIFE SCALE; SCORING SYSTEM; SCRIPT TEST; SENTENCE MEMORY TEST; SOCIAL ASPECT; VERBAL LEARNING TEST; VERBAL MEMORY;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 38349076669     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.08.019     Document Type: Article

References (42)

1. Addington J., and Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophr Res 44 (2000) 47-56
2. Aksaray G., Oflu S., Kaptanoglu C., and Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 1217-1219
3. American Psychiatric Association. Diagnostic and statistical manual of mental Disorders (4th ed. text revision) (1994), American Psychiatric Association Press, Washington, DC
4. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS) (1983), The University of Iowa, Iowa
5. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS) (1984), The University of Iowa, Iowa
6. Andreasen N.C., Flaum M., and Arndt S. The comprehensive assessment of symptoms and history (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49 (1992) 615-623
7. Bilker W.B., Brensinger C., Kurtz M.M., Kohler C., Gur R.C., Siegel S.J., et al. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology 28 (2003) 773-777
8. Censits D.M., Ragland J.D., Gur R.C., and Gur R.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res 24 (1997) 289-298
9. Chan A.S., Chiu H., Lam L., Pang A., and Chow L.Y. A breakdown of event schemas in patients with schizophrenia: an examination of their script for dining at restaurants. Psychiatry Res 7 (1999) 169-181
10. Cohen J. Statistical Power Analysis for the Behavioral Science. 2nd ed. (1988), Academic Press, New York
11. Dickerson F.B., Ringel N.B., and Parente F. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 98 (1998) 124-127
12. Evans J.J., Chua S.E., McKenna P.J., and Wilson B.A. Assessment of the dysexecutive syndrome in schizophrenia. Psychol Med 27 (1997) 635-646
13. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) (1996), American Psychiatric Publishing, Washington DC
14. Fujii D.E., Wylie A.M., and Nathan J.H. Neurocognition and long-term prediction of quality of life in outpatients with severe and persistent mental illness. Schizophr Res 69 (2004) 67-73
15. Green M.F., Kern R.S., Braff D.L., and Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr Bull 26 (2000) 119-136
16. Green M.F., Kern R.S., and Heaton R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72 (2004) 41-51
17. Gur R.C., Ragland J.D., Moberg P.J., Bilker W.B., Kohler C., Siegel S.J., et al. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology 25 (2001) 777-788
18. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia; A quantitative review of the evidence. Neuropsychology 12 (1998) 426-445
19. Heinrichs D.W., Hanlon T.E., and Carpenter Jr. W.T. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10 (1984) 388-398
20. Heslegrave R.J., Awad A.G., and Voruganti L.N. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 22 (1997) 235-243
21. Hofer A., Baumgartner S., Bodner T., Edlinger M., Hummer M., Kemmler G., et al. Patient outcomes in schizophrenia II: the impact of cognition. Eur Psychiatry 20 (2005) 395-402
22. Inagaki A., and Inada T. Dose equivalence of psychotropic drugs: 2006-version. Rinsyou Seisihn Yakuri. Clin Psychopharmacol 9 (2006) 1443-1447 [in Japanese]
23. Kashima H. Japanese Version of Behavioural Assessment of the Dysexecutive Syndrome (2003), Shinkoh Igaku Shuppan, Tokyo
24. Kato K., Matsui M., Kurachi M., Yuuki H., and Suzuki M. Application of brief-neuropsychological scale to the patients with Alzheimer's Disease in early stage. Seishin Igaku 48 (2006) 1301-1307 [in Japanese]
25. Lezak M.D. Neuropsychological Assessment. 3rd ed. (1995), Oxford University Press, New York
26. Matsui M., Sumiyoshi T., Yuuki H., Kato K., and Kurachi M. Impairment of event schema in patients with schizophrenia: examination of script for shopping at supermarket. Psychiatry Res 143 (2006) 179-187
27. Matsui M., Yuuki H., Kato K., and Kurachi M. Impairment of memory organization in patients with schizophrenia or schizotypal disorder. J Int Neuropsychol Soc 12 (2006) 750-754
28. Matsui M., Yuuki H., Kato K., Takeuchi A., Nishiyama S., Bilker W., et al. Schizotypal disorder and schizophrenia: a profile analysis of neuropsychological functioning in Japanese patients. J Int Neuropsychol Soc 13 (2007) 672-682
29. Matsuoka K., Kim Y., Hiro H., Miyamoto Y., Fujita K., Tanaka K., et al. Development of the Japanese Adult Reading Test (JART). Seishin Igaku 44 (2002) 503-511 [in Japanese]
30. Meltzer H.Y. Cognitive factors in schizophrenia: causes, impact, and treatment. CNS Spectrums 9 10 Suppl 11 (2004) 15-24
31. Niendam T.A., Bearden C.E., Johnson J.K., McKinley M., Loewy R., O'Brien M., et al. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res 84 (2006) 100-111
32. Norman R.M., Malla A.K., McLean T., Voruganti L.P., Cortese L., McIntosh E., et al. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand 102 (2000) 303-309
33. Overall J.E., and Gorham D.R. The brief psychiatric rating scale. Psychol Rep 10 (1952) 799-812
34. Ritsner M.S. Predicting quality of life impairment in chronic schizophrenia from cognitive variables. Qual Life Res 16 (2007) 929-937
35. Schank R.C., and Abelson R.P. Script, Plans, Goals and Understanding: An Inquiry Into Human Knowledge Structures (1977), Lawrence Erlbaum Associates, Hillsdale, NJ
36. Shinagawa F., Kobayashi S., Fujita K., and Maekawa H. The Japanese Version of the Wechsler Adult Intelligence Scaled-Revised (1990), Nihon Bunka Kagakusya, Tokyo
37. Smith T.E., Hull J.W., Goodman M., Hedayat-Harris A., Willson D.F., Israel L.M., et al. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 187 (1999) 102-108
38. Sota T.L., and Heinrichs R.W. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Compr Psychiatry 45 (2004) 415-421
39. Wegener S., Redoblado-Hodge M.A., Lucas S., Fitzgerald D., Harris A., and Brennan J. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust NZ J Psychiatry 39 (2005) 87-92
40. Wilson B.A., Adeeman N., Burgess P.W., Emslie H., and Evans J.J. Behavioural Assessment of the Dysexecutive Syndrome (1996), Thames Valley Test Company, England
41. Woodward N.D., Purdon S.E., Meltzer H.Y., and Zald D.H. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 8 (2005) 457-472
42. Wykes T., Reeder C., Landau S., Everitt B., Knapp M., Patel A., et al. Cognitive remediation therapy in schizophrenia: randomised controlled trial. Br J Psychiatry 190 (2007) 421-427